InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
无可用的信号评分。
Explore the complete record of transactions filed by Fickenscher James E, 首席财务官. Director active across 1 company, notably Zynerba Pharmaceuticals, Inc.. Aggregated, 7 disclosures have been published. Breakdown: 0 buy · 1 sell. Total volume traded: €10k. Activity tracked since 26 January 2022. The latest transaction was disclosed on 23 January 2023 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
James E Fickenscher is Directeur Financier and Chief Financial Officer at Zynerba Pharmaceuticals, Inc. He has 7 filings in total, and in the recent sampled filings the period runs from 2022-01-28 to 2023-10-11, with EUR 0 in buys and EUR 9,777 in sells, and the modal transaction nature is Attribution.